Kate Marie Bryan, NP
Nurse Practitioner · Glendora
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 4 years
- Graduated 2022
Offices
1 location · William Gillespie and Associates Inc · 16 clinicians in this group
Hospitals listed: L A Downtown Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Kate Marie Bryan’s office at (626) 914-1980 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- L A Downtown Medical CenterLos Angeles, CAAcute Care Hospital · Proprietary · No emergency departmentOverall rating: 3 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for L A Downtown Medical Center
Behind the star rating — Deaths: 1 better, 3 the same, 0 worse of 4 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 2 the same, 2 worse of 4 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.04 (0 to 2.12) · 141 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.43 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 158 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 6,033 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 6,001 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.28 (0.72 to 5.84) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.55 (0.85 to 4.24) · 125 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.7 (0 to 18.5) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 62 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.23 to 3.28) · 34 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.21 (0 to 0.98) · 5,810 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.5 · 40 cases | None | Apr 2023 – Mar 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 181.6 · 87 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.9 · 28 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 38 cases | None | Jul 2023 – Jun 2025 |
Original Medicare doctor bills
$56,026
Medicare paid this office $56,026 for 320 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 277 | $40,071 | $81 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $10,102 | $117 |
| Initial nursing facility care with high level of medical decision making, per day 50 minutes or more | 14 | $1,809 | $129 |
Who their Medicare patients are
320 Original Medicare patients in 2024. Average age 70 · Under 65 25% · 85 and older 9% · Women 53% · Health risk score 2.65. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 75% · COPD 75% · Depression 75% · Diabetes 57% · Chronic kidney disease 56% · Coronary heart disease 55% · Dementia 54% · Heart failure 44% · Atrial fibrillation 18% · Stroke 15% · Cancer 8%.
The office billed $114,915, Medicare allowed $72,629 and paid $56,026; for 677 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 320 | 677 | 70 | 2.65 | $114,915 | $56,026 |
| 2023 | 128 | 222 | 72 | 2.54 | $42,778 | $18,907 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 105 | $12,794 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $2,717 | $124 |
Drugs they prescribed that Part D paid
$52,859
Pharmacies billed $52,859 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 160) in 2024. At or below the middle of the specialty; the typical nurse practitioner clinician is at 0%.
136 generic and 24 brand-name prescriptions · $52,859 in drug cost · 21 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vraylar | 17 | $37,844 | $2,226 |
| Bupropion Xl | 16 | $505 | $32 |
| Buspirone | 11 | $317 | $29 |
| Fluoxetine | 13 | $269 | $21 |
| Lamotrigine | 18 | $152 | $8 |
See all 6 drugs
| Vraylar | 17 | $37,844 | $2,226 |
| Bupropion Xl | 16 | $505 | $32 |
| Buspirone | 11 | $317 | $29 |
| Fluoxetine | 13 | $269 | $21 |
| Lamotrigine | 18 | $152 | $8 |
| Trazodone | 13 | $140 | $11 |
Year by year
| 2024 | 160 | None | 0% (0) | 15% | $52,859 |
| 2023 | 81 | None | 0% (0) | None | $17,130 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Money from drug and device companies
$125 in 2025
| 2025 | 1 | 1 | None | $125 |
| 2024 | 1 | 1 | None | $110 |
| 2023 | 2 | 2 | None | $33 |
| 2022 | 2 | 2 | None | $160 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $125 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2025-02-13 | Cobenfy | $125 |
See earlier years (2024, 2023, 2022)
2024: $110
| Janssen Pharmaceuticals | Spravato | $110 | 1 payment
|
2023: $33
| Abbvie | Vraylar | $17 | 1 payment
|
| Idorsia Pharmaceuticals US | Quviviq | $16 | 1 payment
|
2022: $160
| Otsuka Pharmaceutical Development & Commercialization | Jynarque | $100 | 1 payment
|
| Iti | Caplyta | $59 | 1 payment
|
Professional record
- NPI
- 1578286738
- Licence
- CA 95022498
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 363LP0808X (363LP0808X)
- Mailing address
- 510 S Grand Ave, Glendora, CA, 91741
- NPI first listed
- 2022-09-22
- NPI last updated
- 2025-02-03
- NPI record certified
- 2025-02-03
This is when the NPI record was last certified, not a medical board exam.